Bold headlines linking blockbuster gene-editing tool CRISPR to cancer sent stocks in companies trying to bring the technology to medicine tumbling. But scientists who study the technique say the concerns are overblown at best and an incorrect interpretation of the science at worst. Ultimately, using CRISPR does not appear to […]
The FDA just put a hold on one of the first trials to test the CRISPR gene-editing technology in humans. The trial hadn’t begun yet. The trial, run by CRISPR Therapeutics and Vertex Pharmaceuticals, plans to look at how the gene-editing technology works to treat patients with sickle cell disease. […]
Companies that develop medications using the revolutionary gene-editing technology CRISPR took a hit on Monday after a study found some concerns about an immune response to the technology. CRISPR Therapeutics dropped sharply on Monday before rebounding, ending the day down 2.8%. Intellia Therapeutics and Editas Medicine both fell by about […]
One of the companies that hopes to turn a...